Ojjaara 100 mg (Momelotinib (Momelotinib Dihydrochloride) TABLET) 100 MG

OJJAARA 100 MG tablets contain momelotinib dihydrochloride, a medication used for managing certain conditions. This oral tablet is manufactured by GlaxoSmithKline Inc. in Canada.

Strength

100 MG

Manufacturer / TM Owner

GLAXOSMITHKLINE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

OJJAARA 100 MG tablets are primarily used for managing specific medical conditions. Momelotinib dihydrochloride, the active ingredient, is often prescribed to address symptoms related to these conditions. Patients may wonder, 'What is momelotinib used for?' Typically, it is utilized in therapeutic regimens to alleviate discomfort and improve quality of life.

Side Effects

Common effects of OJJAARA 100 MG tablets may include mild gastrointestinal discomfort, fatigue, or dizziness. Individual responses can vary, and not everyone will experience these effects. It's important to monitor how the body reacts to the medication and consult a healthcare provider if any concerns arise.

Precautions & Warnings

When handling OJJAARA 100 MG tablets, it's crucial to follow the prescribed guidelines. Store the medication in a cool, dry place away from direct sunlight. Always keep it out of reach of children and pets. Adhere to the recommended usage instructions to ensure safety and effectiveness.

Avoid Interactions

OJJAARA 100 MG tablets may interact with certain substances, including alcohol and other medications. It's advisable to avoid alcohol while taking this medication. Additionally, inform your healthcare provider about all other medications you are taking to prevent potential interactions.

References

Frequently Asked Questions

OJJAARA 100 MG tablets are used to manage specific medical conditions. The active ingredient, momelotinib dihydrochloride, helps alleviate symptoms related to these conditions.

OJJAARA 100 MG tablets are taken orally. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include mild gastrointestinal discomfort, fatigue, or dizziness. Individual responses can vary.

It is advisable to avoid alcohol while taking OJJAARA 100 MG tablets to prevent potential interactions.

Store OJJAARA 100 MG tablets in a cool, dry place away from direct sunlight and keep them out of reach of children and pets.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.